when will compounded tirzepatide be unavailable New Weight Management Program Q&A What Is Compounded Tirzepatide?

North Carolina eliminated GLP-1 coverage beginning October 2025 due to a budget stalemate in the legislature, but coverage was reinstated in December 2025, bringing the total number of states covering GLP-1s for obesity to 13 as of January 2026

High-performance liquid chromatography (HPLC) is used to confirm molecular identity and verify purity levels exceeding 99.9%, helping ensure consistent physicochemical properties across production batches

Alcohol also dehydrates you and impairs the glucose regulation that tirzepatide supports, making it counterproductive for weight loss

As weight decreases, many patients experience additional benefits such as improved energy levels, reduced joint strain, and better cardiovascular markers like cholesterol and blood pressure

You can also contact MotherToBaby or similar teratology information services for evidence summaries on medications and breastfeeding

However, on December 19, 2024, the FDA and OFA jointly filed an update on the FDAs decision to reevaluate the shortage status of tirzepatide